Terms: = Germ cell tumor AND B2M, P61769, 567, ENSG00000166710
132 results:
1. Robot-assisted versus laparoscopic pheochromocytoma resection and construction of a nomogram to predict perioperative hemodynamic instability.
Huang H; Sun T; Liu Z
Eur J Surg Oncol; 2024 Mar; 50(3):107986. PubMed ID: 38325143
[TBL] [Abstract] [Full Text] [Related]
2. tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma.
Versluis JM; Hoefsmit EP; Shehwana H; Dimitriadis P; Sanders J; Broeks A; Blank CU
Cancer Immunol Immunother; 2024 Jan; 73(2):28. PubMed ID: 38280045
[TBL] [Abstract] [Full Text] [Related]
3. PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma.
Ellebaek E; Khan S; Bastholt L; Schmidt H; Haslund CA; Donia M; Svane IM
Eur J Cancer; 2024 Feb; 198():113476. PubMed ID: 38171116
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
Drebin HM; Hosein S; Kurtansky NR; Nadelmann E; Moy AP; Ariyan CE; Bello DM; Brady MS; Coit DG; Marchetti MA; Bartlett EK
J Am Coll Surg; 2024 Jan; 238(1):23-31. PubMed ID: 37870230
[TBL] [Abstract] [Full Text] [Related]
5. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
[TBL] [Abstract] [Full Text] [Related]
6. Antitumor Immune Responses in b2m-Deficient Cancers.
Torrejon DY; Galvez M; Abril-Rodriguez G; Campbell KM; Medina E; Vega-Crespo A; Kalbasi A; Comin-Anduix B; Ribas A
Cancer Immunol Res; 2023 Dec; 11(12):1642-1655. PubMed ID: 37801341
[TBL] [Abstract] [Full Text] [Related]
7. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
[No Abstract] [Full Text] [Related]
8. [Application of synthetic MRI in predicting isocitrate dehydrogenase 1 genotypes in gliomas].
Ge X; Yang ZH; Shen Y; Liu WX; Zhai XF; Ma WF; Wang ML; Zhang W; Wang XD
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(33):2619-2623. PubMed ID: 37650209
[TBL] [Abstract] [Full Text] [Related]
9. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
10. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
[TBL] [Abstract] [Full Text] [Related]
11. Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT).
Neyaz A; Crotty R; Rickelt S; Pankaj A; Stojanova M; Michelakos TP; Sekigami Y; Kontos F; Parrack PH; Patil DT; Heaphy CM; Ferrone CR; Deshpande V
Histopathology; 2023 Oct; 83(4):546-558. PubMed ID: 37455385
[TBL] [Abstract] [Full Text] [Related]
12. Uncoupling CD4+ TIL-Mediated tumor Killing from JAK-Signaling in Melanoma.
Draghi A; Presti M; Jensen AWP; Chamberlain CA; Albieri B; Rasmussen AK; Andersen MH; Crowther MD; Svane IM; Donia M
Clin Cancer Res; 2023 Oct; 29(19):3937-3947. PubMed ID: 37126006
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic control of
Wang MM; Koskela SA; Mehmood A; Langguth M; Maranou E; Figueiredo CR
Front Immunol; 2023; 14():1152228. PubMed ID: 37077920
[TBL] [Abstract] [Full Text] [Related]
14. Induction of Immune-Stimulating Factors and Oncolysis Upon p14
Mendonça SA; Antunes F; Cerqueira OLD; Del Valle PR; Hunger A; Oliveira PVS; Brito B; Costanzi-Strauss E; Strauss BE
DNA Cell Biol; 2023 Jun; 42(6):274-288. PubMed ID: 36576491
[TBL] [Abstract] [Full Text] [Related]
15. Real-world clinical outcomes of patients with stage IIB or IIC cutaneous melanoma treated at US community oncology clinics.
Samlowski W; Silver MA; Hohlbauch A; Zhang S; Scherrer E; Fukunaga-Kalabis M; Krepler C; Jiang R
Future Oncol; 2022 Oct; 18(33):3755-3767. PubMed ID: 36346064
[TBL] [Abstract] [Full Text] [Related]
16. [Analysis of progress characteristics of retinoblastoma based on single cell transcriptome sequencing].
Xu K; Nie W; Tong Q; Ma L; Liu J; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3809-3824. PubMed ID: 36305411
[TBL] [Abstract] [Full Text] [Related]
17. [Enhanced Natural Killers with CISH and b2m Gene Knockouts Reveal Increased Cytotoxicity in Glioblastoma Primary Cultures].
Yusubalieva GM; Dashinimaev EB; Gorchakov AA; Kulemzin SV; Brovkina OA; Kalinkin AA; Vinokurov AG; Shirmanova MV; Baklaushev VP
Mol Biol (Mosk); 2022; 56(5):848-859. PubMed ID: 36165021
[TBL] [Abstract] [Full Text] [Related]
18. Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy.
Nielsen M; Presti M; Sztupinszki Z; Jensen AWP; Draghi A; Chamberlain CA; Schina A; Yde CW; Wojcik J; Szallasi Z; Crowther MD; Svane IM; Donia M
Cancer Immunol Res; 2022 Oct; 10(10):1254-1262. PubMed ID: 35969233
[TBL] [Abstract] [Full Text] [Related]
19.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract] [Full Text] [Related]
20. β2-Microglobulin Maintains Glioblastoma Stem cells and Induces M2-like Polarization of tumor-Associated Macrophages.
Li D; Zhang Q; Li L; Chen K; Yang J; Dixit D; Gimple RC; Ci S; Lu C; Hu L; Gao J; Shan D; Li Y; Zhang J; Shi Z; Gu D; Yuan W; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Shi Y; You Y; Zhang N; Rich JN; Wang X
Cancer Res; 2022 Sep; 82(18):3321-3334. PubMed ID: 35841593
[TBL] [Abstract] [Full Text] [Related]
[Next]
